Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuromodec is a global organization and digital platform that serves as a central hub for the neuromodulation and neurotechnology communities. Founded by Professor Marom Bikson of The City College of New York, the platform provides a comprehensive directory of clinical specialists, educational resources, and a job board for professionals in the field. Neuromodec is primarily recognized for organizing the NYC Neuromodulation conference and publishing the Neuromodec Journal, which focuses on advancements in brain stimulation technologies such as tDCS, TMS, and DBS. The organization also offers specialized training courses and computational modeling tools to support the design and implementation of personalized neuromodulation therapies. By facilitating collaboration between academia, industry, and clinicians, Neuromodec aims to accelerate the development and clinical adoption of non-invasive and implantable neurotechnologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuromodec.